eprozinol

Comparison of eprosartan and losartan in patients with mild to moderate essential hypertension;

依普罗沙坦与氯沙坦在轻中度原发性高血压病人中的降压疗效比较

Metabolism of eprosartan does not require the cytochrome P450 enzyme system and has less drug-drug interactions.

依普罗沙坦是一个新型、高选择性血管紧张肽Ⅱ受体1拮抗药,尚具有改善血管内皮功能、延迟动脉粥样硬化、抗炎症等作用。